The putative P-gp inhibitor telmisartan does not affect the transcellular permeability and cellular uptake of the calcium channel antagonist verapamil in the P-glycoprotein expressing cell line MDCK II MDR1.

导出 LinkOut

翻译打印收藏纠错

第一作者： Lasse,Saaby

第一单位： Bioneer:FARMA, Faculty of Health and Medical Sciences, University of Copenhagen, Glostrup Hospital Glostrup, Denmark ; Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen Copenhagen, Denmark.

作者： Lasse,Saaby ^[1] ; Peer,Tfelt-Hansen ^[2] ; Birger,Brodin ^[3]

作者单位： Bioneer:FARMA, Faculty of Health and Medical Sciences, University of Copenhagen, Glostrup Hospital Glostrup, Denmark ; Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen Copenhagen, Denmark. ^[1] Danish Headache Center, Department of Neurology, Glostrup Hospital, University of Copenhagen Glostrup, Denmark. ^[2] Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen Copenhagen, Denmark. ^[3]

关键词 Blood–brain barrier P-glycoprotein cluster headache telmisartan verapamil

DOI 10.1002/prp2.151

PMID 26171231

发布时间 2018-11-13

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览19

Pharmacology research & perspectives

2015年3卷4期

e00151页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

The putative P-gp inhibitor telmisartan does not affect the transcellular permeability and cellular uptake of the calcium channel antagonist verapamil in the P-glycoprotein expressing cell line MDCK II MDR1.

Pharmacology research & perspectives

相似文献

Pharmacology research & perspectives

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

The putative P-gp inhibitor telmisartan does not affect the transcellular permeability and cellular uptake of the calcium channel antagonist verapamil in the P-glycoprotein expressing cell line MDCK II MDR1.

Pharmacology research & perspectives

相似文献

Pharmacology research & perspectives

相关期刊

检索历史清除